EMYRIA
Emyria Limited is a data-backed clinical drug development and care delivery company focused on accelerating treatment development and improving patient care.
EMYRIA
Address:
Perth, Western Australia, Australia
Country:
Australia
Website Url:
http://www.emyria.com
Total Employee:
11+
Status:
Active
Contact:
1300 436 363
Total Funding:
5 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Novan
Novan is a clinical-stage drug development company developing deliverable nitric oxide.
ResApp Health
ResApp is developing digital healthcare solutions to assist doctors
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Summit Therapeutics
Summit Therapeutics is a clinical-stage drug discovery and development company.
Current Employees Featured
Founder
Stock Details
Investors List
Tattarang
Tattarang investment in Post-IPO Equity - Emyria
Official Site Inspections
http://www.emyria.com Semrush global rank: 6.08 M Semrush visits lastest month: 1.34 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Emyria"
Emyria - Crunchbase Company Profile & Funding
Emyria is developing a range of MDMA analogues for various medical indications, including faster-acting MDMA and treatments for Parkinson’s disease. Ultra-Pure CBD capsules Emyria …See details»
Emyria (ASX:EMD) - LinkedIn
Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model: Emyria Clinics: …See details»
Emyria - AnnualReports.com
Emyria doing it by developing technology-powered health services that elevate clinical care and deliver deeper clinical insights. Their is a collaborative vision and venture. They’re bringing …See details»
Emyria (ASX:EMD) Company Profile & Description - Stock Analysis
3 days ago Emyria Limited engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia. It develops MDMA …See details»
Emyria - The Org
Emria is a data-backed drug development and care delivery company. Headquarters. Perth, Australia. Employees. 11-50See details»
Emyria - businessabc.net
Feb 25, 2025 Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia. History Emyria was founded in 2005 with a vision to provide powerful and scalable …See details»
Emyria - Contacts, Employees, Board Members, Advisors & Alumni …
Experience the new Crunchbase, powered by AI . Organization. EmyriaSee details»
Emyria - Company Overview - Nov 2022
Emyria’s Real World Data (RWD) 9 How Emyria’s RWD supports clinical development 10 - 12 Emyria’s Clinical Programs 13 Ultra-Pure cannabinoid delivery platform 14 - 15 Ultra-Pure …See details»
Emyria Company Profile - Office Locations, Competitors, Revenue …
Oct 4, 2024 Emyria $2.2 m in annual revenue in FY 2024. See insights on Emyria including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About emyria | Emyria Limited
View share price, top shareholders, your shareholding, and interact with announcements for Emyria.See details»
Emyria Limited - Company Profile Report | IBISWorld
Emyria is listed on the Australian Securities Exchange under the code EMD. Emyria Limited - Products & Brands. Emyria Limitedcreates conducts drug development programs that are …See details»
Emyria Limited (ASX:EMD) - Intelligent Investor
Apr 1, 2025 Relative to the previous close share price of $0.03, Emyria Limited's (EMD) current share price of $0.03 constitutes a movement of or 0%. Emyria Limited's (EMD) share price …See details»
Emyria | ASX-Listed, Clinics & Doctors, Consulting, Medical
Emyria is also the owner of Emerald Clinics (ASX: EMD), an alternative healthcare provider that serves 5,000+ Australians and patients in the UK. You may know Emyria from its work with …See details»
Emyria announces key leadership changes - Biotech
Jan 22, 2025 Dr Winlo added, "2025 is set to be a transformative year for Emyria driven by Mr Hutchinson’s expertise growing clinical services and our expanding engagement with payers. I …See details»
Meet the team | Emyria Limited
View share price, top shareholders, your shareholding, and interact with announcements for Emyria.See details»
Emyria partners with Mind Medicine Australia to develop national …
[email protected] [email protected] Mind Medicine Australia’s contact details are; Peter Hunt Chairman +61 (0) 419 271 483 [email protected] …See details»
emyria.com Reviews: Is this site a scam or legit?
Is emyria.com legit? It's definitely questionable. If you plan to do business on this site, proceed with caution as it received a medium score on our chart. We put to work 53 powerful factors to …See details»
New investors - Emyria Limited
View share price, top shareholders, your shareholding, and interact with announcements for Emyria.See details»
Why invest in emyria? | Emyria Limited
View share price, top shareholders, your shareholding, and interact with announcements for Emyria.See details»